BioWorld MedTech

Aug. 6, 2012

View Archived Issues

Report from Europe: TFS implements Medidata's CTMS to expanding base

Washington roundup: NEJM's article on to-market times omits duration of trials

Agreements/contracts: Humana reports in-network access to Tenent subsidiaries

Deals roundup: Opko Health acquires Farmadiet Group Holding

Restructuring roundup: NeoGenomics to expand Fort Myers headquarters

People in the News

Financings roundup: Globus price Class A stock at $12 per share

Product Briefs

MDD's Neurology Extra

FDA clears ingestible sensor from Proteus for smart drugs

Proteus Digital Health (Redwood City, California) has received FDA clearance for its ingestible sensor technology for marketing as a medical device. Read More

DePuy Synthes gets FDA OK for scoliosis systems

Today's news in brief

BioWorld

BioWorld briefs for June 12, 2026.

Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

BioWorld

Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...

Ethyreal launches to treat the underlying cause of Graves’, TED

BioWorld

Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...

Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?

BioWorld

Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...

Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists

BioWorld Science

Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.